Log In
Print this Print this

Thelin, sitasentan

Also known as: Sitaxsentan (PF-1228305, TBC11251)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSmall molecule endothelin A receptor antagonist
Molecular Target Endothelin A receptor
Mechanism of ActionEndothelin A receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat Eisenmenger syndrome (ES); Treat mild to moderate hypertension; Treat pulmonary arterial hypertension (PAH); Treat pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH); Treat pulmonary arterial hypertension (PAH) in patients who previously failed bosentan; Treat pulmonary hypertension (PH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today